Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Scientific Reports|July 8, 2021
The first insight into the genetic structure of the population of modern SerbiaTamara Drljaca, Branka Zukic, Vladimir Kovacevic, et al.
Journal of Cellular Biochemistry|April 3, 2012
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemiaManuela Mancini, Nevena Veljkovic, Elisa Leo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 9, 2007
EMILINs interact with anthrax protective antigen and inhibit toxin action in vitroRoberto Doliana, Veljko Veljkovic, Jelena Prljic, et al.
Traffic (Copenhagen, Denmark)|February 18, 2009
14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemiaManuela Mancini, Nevena Veljkovic, Valentina Corradi, et al.
Plos One|May 10, 2013
Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmissionVladimir R Perovic, Claude P Muller, Henry L Niman, et al.
Cancers|July 24, 2021
Meta-Analysis of Circulating Cell-Free DNA's Role in the Prognosis of Pancreatic CancerJelena Milin-Lazovic, Petar Madzarevic, Nina Rajovic, et al.
Current HIV Research|September 28, 2007
The presence of antibodies recognizing a peptide derived from the second conserved region of HIV-1 gp120 correlates with non-progressive HIV infectionAna Djordjevic, Milena Veljkovic, Sascha Antoni, et al.
Frontiers in Cellular and Infection Microbiology|April 12, 2019
Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel InhibitorsDraginja Radosevic, Milan Sencanski, Vladimir Perovic, et al.
F1000Research|February 27, 2015
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infectionVeljko Veljkovic, Philippe M Loiseau, Bruno Figadere, et al.
Viral Immunology|April 1, 2011
A bioinformatics approach to identify natural autoantibodies from healthy blood donors' sera reactive with the HCV NS5A-derived peptide by immunoassayNada Vasiljevic, Nevena Veljkovic, Tatjana Kosec, et al.
Pageof 6